Sign in
8-K

Current Report

X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-032627

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading xfor-20250623.htm…